Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 15, 2010, Pages 6964-6969

  Lev, Avital ^a   Princiotta, Michael F ^b   Zanker, Damian ^c   Takeda, Kazuyo ^a   Gibbs, James S ^a   Kumagai, Chiharu ^b   Waffarn, Elizabeth ^a   Dolan, Brian P ^a   Burgevin, Anne ^d   Van Endert, Peter ^d   Chen, Weisan ^c   Bennink, Jack R ^a   Yewdell, Jonathan W ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^d INSERM   (France)

Author keywords

MHC; Peptide; Translation; Virus

Indexed keywords

CELL PROTEIN; GENE PRODUCT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; RIBOSOME PROTEIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CD8+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; CYTOSOL; IMMUNOSURVEILLANCE; MASS ACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINIA VIRUS;

ANIMALS; ANTIGEN PRESENTATION; BINDING, COMPETITIVE; CD8-POSITIVE T-LYMPHOCYTES; CYTOSOL; FLOW CYTOMETRY; GENES, MHC CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS I; KINETICS; LIGANDS; MICE; MODELS, BIOLOGICAL; MONITORING, IMMUNOLOGIC; PEPTIDES; PROTEIN BINDING;

EID: 77951072459     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0910997107     Document Type: Article

References (34)

1. - mutation. Proc Natl Acad Sci USA 85:2274-2278.
2. Shastri N, Schwab S, Serwold T (2002) Producing nature's gene chips: The generation of peptides for display by MHC class I molecules. Annu Rev Immunol 20:463-493. (Pubitemid 34293432)
3. Yewdell JW, Reits E, Neefjes J (2003) Making sense of mass destruction: Quantitating MHC class I antigen presentation. Nat Rev Immunol 3:952-961. (Pubitemid 37521537)
4. Yewdell JW, Nicchitta CV (2006) The DRiP hypothesis decennial: Support, controversy, refinement and extension. Trends Immunol 27:368-373.
5. Fruci D, et al. (2003) Quantifying recruitment of cytosolic peptides for HLA class I presentation: Impact of TAP transport. J Immunol 170:2977-2984. (Pubitemid 36302170)
6. Porgador A, Gilboa E (1995) Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J Exp Med 182:255-260.
7. Lev A, et al. (2008) The exception that reinforces the rule: Cross-priming by cytosolic peptides that escape degradation. Immunity 28:787-798. (Pubitemid 351778406)
8. + T cell responses to influenza A virus: Roles for cross-presentation and lysis-independent immunodomination. J Immunol 173:5021-5027.
9. Princiotta MF, et al. (2003) Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18:343-354.
10. Antón LC, et al. (1999) Intracellular localization of proteasomal degradation of a viral antigen. J Cell Biol 146:113-124.
11. Falk K, Rötzschke O, Rammensee HG (1990) Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature 348:248-251. (Pubitemid 20383091)
12. + T cell determinants to enable rational design and characterization of smallpox vaccines. J Exp Med 201:95-104.
13. López D, Samino Y, Koszinowski UH, Del Val M (2001) HIV envelope protein inhibits MHC class I presentation of a cytomegalovirus protective epitope. J Immunol 167:4238-4244. (Pubitemid 32954297)
14. Ben-Shahar S, et al. (1999) 26 S proteasome-mediated production of an authentic major histocompatibility class I-restricted epitope from an intact protein substrate. J Biol Chem 274:21963-21972. (Pubitemid 129519751)
15. Weinzierl AO, et al. (2007) Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface. Mol Cell Proteomics 6:102-113.
16. Fortier MH, et al. (2008) The MHC class I peptide repertoire is molded by the transcriptome. J Exp Med 205:595-610.
17. Gu WY, et al. (2009) Both treated and untreated tumors are eliminated by short-hairpin RNA-based induction of target-specific immune responses. Proc Natl Acad Sci USA 106:8314-8319.
18. Hosaka Y, Sasao F, Yamanaka K, Bennink JR, Yewdell JW (1988) Recognition of noninfectious influenza virus by class I-restricted murine cytotoxic T lymphocytes. J Immunol 140:606-610. (Pubitemid 18056791)
19. Villanueva MS, Fischer P, Feen K, Pamer EG (1994) Efficiency of MHC class I antigen processing: A quantitative analysis. Immunity 1:479-489. (Pubitemid 2142272)
20. Guermonprez P, et al. (2003) ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 425:397-402. (Pubitemid 37187268)
21. Burgdorf S, Kautz A, Bohnert V, Knolle PA, Kurts C (2007) Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 316:612-616. (Pubitemid 46683149)
22. Burgdorf S, Schölz C, Kautz A, Tampé R, Kurts C (2008) Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nat Immunol 9:558-566. (Pubitemid 351560525)
23. Hudder A, Nathanson L, Deutscher MP (2003) Organization of mammalian cytoplasm. Mol Cell Biol 23:9318-9326.
24. Stapulionis R, Deutscher MP (1995) A channeled tRNA cycle during mammalian protein synthesis. Proc Natl Acad Sci USA 92:7158-7161.
25. Wearsch PA, Cresswell P (2008) The quality control of MHC class I peptide loading. Curr Opin Cell Biol 20:624-631.
26. Tussey LG, et al. (1995) Different MHC class I alleles compete for presentation of overlapping viral epitopes. Immunity 3:65-77.
27. Ortmann B, et al. (1997) A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes.. Science 277:1306-1309. (Pubitemid 27449083)
28. Rufer E, Leonhardt RM, Knittler MR (2007) Molecular architecture of the TAP-associated MHC class I peptide-loading complex. J Immunol 179:5717-5727.
29. Qian SB, et al. (2006) Tight linkage between translation and MHC class I peptide ligand generation implies specialized antigen processing for defective ribosomal products. J Immunol 177:227-233.
30. Reits EA, Vos JC, Grommé M, Neefjes J (2000) The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 404:774-778.
31. Wheatley DN, Inglis MS (1980) An intracellular perfusion system linking pools and protein synthesis. J Theor Biol 83:437-445.
32. Chakrabarti S, Brechling K, Moss B (1985) Vaccinia virus expression vector: Coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol Cell Biol 5:3403-3409. (Pubitemid 16233047)
33. Anton LC, Yewdell JW, Bennink JR (1997) MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. J Immunol 158:2535-2542.
34. Chen W, Antón LC, Bennink JR, Yewdell JW(2000) Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 12:83-93. (Pubitemid 30069217)